Don’t Let Bipolar Disorder Break the Bank!

February 25, 2011

The Bipolar Disorder Survival Guide, a book by David Miklowitz, professor of psychiatry and director of the child and adolescent mood disorders program at the Semel Institute, was highlighted Feb. 25 on, and featured a chapter excerpt about managing money.

Non-invasive therapy significantly improves depression, UCLA researchers say

September 2, 2010

Major depression is a common and disabling brain condition marked not only by the presence of depressed mood but also by its effects on sleep, energy, decision-making, memory and thoughts of death or of suicide.

Simple test can detect signs of suicidal thoughts in people taking antidepressants

April 8, 2010

While antidepressant medications have proven to be beneficial in helping people overcome major depression, it has long been known that a small subset of individuals taking these drugs can actually experience a worsening of mood, and even thoughts of suicide.

Antidepressants – More than a Mood Changer?

January 11, 2010

Ian Cook, Miller Family Professor of Psychiatry and director of the Depression Research Program at the Semel Institute, was interviewed on the Dec. 7 KPCC 89.3FM “Patt Morrison Show” about a report in the December Archives of General Psychiatry that states the bio-chemical properties of at least one common anti-depressant may actually be producing real personality changes.

Dying for Help: A Stark Look at Teen Mental Health

November 6, 2009

Dr. James McGough, professor of clinical psychiatry at the Semel Institute, appeared in a special report by KBFX Ch. 58 (Bakersfield) airing Nov. 1 and Nov. 4 about teenage mental illness. McGough talked about his intervention with a teen diagnosed with bipolar disorder.

UCLA researchers develop biomarker for rapid relief of major depression

September 10, 2009

It is a long, slow slog to treat major depression. Many antidepressant medications are available, but no single biomarker or diagnostic test exists to predict which one is right for an individual. As a result, for more than half of all patients, the first drug prescribed doesn't work, and it can take months to figure out what does.